This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lopez, L R Articles by Garcia-De La Torre, I Search for Related Content PubMed PubMed Citation Articles by Lopez, L R Articles by Garcia-De La Torre, I Social Bookmarking                         What's this?

Oxidized low-density lipoprotein and ß2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis

Corgenix, Inc., Westminster, Colorado, USA, llopez{at}corgenix.com

M Salazar-Paramo

Research Division, Hospital de Especialidades, CMNO, IMSS, Guadalajara, Mexico

C Palafox-Sanchez

Department of Immunology and Rheumatology, Hospital General de Occidente and Department of Physiology, CUCS, University of Guadalajara, Guadalajara, Mexico

B L Hurley

Corgenix, Inc., Westminster, Colorado, USA

E Matsuura

Department of Cell Chemistry, University of Okayama Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

I Garcia-De La Torre

Department of Immunology and Rheumatology, Hospital General de Occidente and Department of Physiology, CUCS, University of Guadalajara, Guadalajara, Mexico

Oxidative stress and LDL modification (oxLDL) are early pro-atherogenic events. OxLDL binds ß2GPI producing immunogenic oxLDL/ß2GPI complexes. Antibodies to these complexes have been associated with arterial thrombosis in patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). Circulating oxLDL/ß2GPI complexes, IgG and IgM antibodies to these complexes were measured by ELISA in 30 SLE patients asymptomatic for cardiovascular disease (mean age 31 years) and 27 age/sex matched healthy controls. Carotid intima-media thickness (IMT) was measured by ultrasound in all patients and controls. Forty-seven percent of SLE presented plaques (median IMT of 0.65 ± 0.12 mm) while only 7% of the controls had plaques (median IMT of 0.50 ± 0.04 mm, P < 0.001). Median optical density (OD_450nm) for oxLDL/ß2GPI complexes in SLE was 0.244 ± 0.07, higher than controls (0.174 ± 0.09, P < 0.001). Median OD for IgG anti-oxLDL/ß2GPI antibodies was also higher in SLE (0.297 ± 0.26) compared to controls (0.194 ± 0.07, P < 0.001) while the median OD for IgM antibodies in SLE (0.444 ± 0.46) was not different than controls (0.326 ± 0.22, P = 0.267). There was no correlation between IMT and oxLDL/ß2GPI complexes, IgG or IgM antibodies, possibly reflecting the complex interrelationship between these serologic elements and tissue factors in the arterial wall. These results support the hypothesis that oxLDL/ß2GPI complexes and IgG (not IgM) anti-oxLDL/ß2GPI antibodies contribute to the development of autoimmune-mediated atherosclerosis

Key Words: autoimmune-mediated atherosclerosis • ß2-glycoprotein I • intima-media thickness • oxidized low-density lipoprotein • systemic lupus erythematosus

Lupus, Vol. 15, No. 2, 80-86 (2006)
DOI: 10.1191/0961203306lu2267oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				E. M. Urbina, R. V. Williams, B. S. Alpert, R. T. Collins, S. R. Daniels, L. Hayman, M. Jacobson, L. Mahoney, M. Mietus-Snyder, A. Rocchini, et al. Noninvasive Assessment of Subclinical Atherosclerosis in Children and Adolescents: Recommendations for Standard Assessment for Clinical Research: A Scientific Statement From the American Heart Association Hypertension, November 1, 2009; 54(5): 919 - 950. [Abstract] [Full Text] [PDF]

				C. A. Palafox-Sanchez, M. Vazquez-Del Mercado, G. Orozco-Barocio, I. Garcia-De la Torre, N. Torres-Carrillo, N. M. Torres-Carrillo, B. Illades-Aguiar, and J. F. Munoz-Valle A Functional Ser413/Ser413 PAI-2 Polymorphism Is Associated With Susceptibility and Damage Index Score in Systemic Lupus Erythematosus Clinical and Applied Thrombosis/Hemostasis, April 1, 2009; 15(2): 233 - 238. [Abstract] [PDF]

				H. Loppnow, K. Werdan, and M. Buerke Invited review: Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms Innate Immunity, April 1, 2008; 14(2): 63 - 87. [Abstract] [PDF]

				S. Ardoin, C. Sandborg, and L. Schanberg Review: Management of dyslipidemia in children and adolescents with systemic lupus erythematosus Lupus, August 1, 2007; 16(8): 618 - 626. [Abstract] [PDF]

				M. Tabuchi, K. Inoue, H. Usui-Kataoka, K. Kobayashi, M. Teramoto, K. Takasugi, K. Shikata, M. Yamamura, K. Ando, K. Nishida, et al. The association of C-reactive protein with an oxidative metabolite of LDL and its implication in atherosclerosis J. Lipid Res., April 1, 2007; 48(4): 768 - 781. [Abstract] [Full Text] [PDF]

				E Matsuura, K Kobayashi, B. Hurley, and L. Lopez Atherogenic Oxidized Low-Density Lipoprotein/{beta}2-Glycoprotein I (oxLDL/{beta}2GPI) Complexes in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome Lupus, July 1, 2006; 15(7): 478 - 483. [Abstract] [PDF]